Mervat Z. Azzouni-El
Alexandria, ALX, Egypt
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Schistosomiasis mansoni: A new therapeutic target for ubiquinol, a natural inhibitor of neutral magnesium-dependent sphingomyelinase in murine model.
Journal: Acta tropica
Published: March 12, 2021
Evaluation of prophylactic efficacy and safety of praziquantel-miltefosine nanocombination in experimental Schistosomiasis mansoni.
Journal: Acta tropica
Published: March 04, 2020
Single oral fixed-dose praziquantel-miltefosine nanocombination for effective control of experimental schistosomiasis mansoni.
Journal: Parasites & vectors
Published: February 08, 2020
Praziquantel-lipid nanocapsules: an oral nanotherapeutic with potential Schistosoma mansoni tegumental targeting.
Journal: International journal of nanomedicine
Published: August 21, 2018
Immuno-therapeutic potential of Schistosoma mansoni and Trichinella spiralis antigens in a murine model of colon cancer.
Journal: Investigational new drugs
Published: February 04, 2018
Treatment of Schistosoma mansoni with miltefosine in vitro enhances serological recognition of defined worm surface antigens.
Journal: PLoS neglected tropical diseases
Published: April 11, 2017
Miltefosine lipid nanocapsules: Intersection of drug repurposing and nanotechnology for single dose oral treatment of pre-patent schistosomiasis mansoni.
Journal: Acta tropica
Published: October 28, 2015
Showing 1-8 of 8
Last Updated: 09/26/2026